Loading...

AJOONI Ajooni Biotech Ltd Changes in capital structure Announcement

jn B

JN

Ajooni Biotech Ltd

(AJOONI)

2025 Announcement

Manufacturing expansion

Un-audited results

Unaudited Financial Results

Un-Audited Results

New Plant Update

New Plant Update

Confirmation Certificate Su...

Revised Scrutinizer Report

General Updates

Management Change

AGM Results Submitted

AGM Proceedings

Trading Window Closure

New Customer Order

Annual General Meeting

Annual General Meeting

Record Date Set

Change in Auditors

Board Meeting Outcomes

Major Order Secured

No Deviation Report

Financial Results Update

Financial Results

Board Meeting Outcome

Confirmation Certificate

Clarification on Results

Management Change

Trading Window Closure

Disclosure Submission

Strong Q4 Results

No Fund Deviations

Financial Results Submitted

Board Meeting Results

Disclosure Submission

Regulatory Disclosure

Management Changes

Board Meeting Outcome

Convertible Warrants Withdr...

Board Meeting Outcome

Disclosure Submitted

Regulatory Submission

Cautionary Notice

Trading Window Closure

Financial Filing Update

Director Appointment Update

Financial Results Published

No Fund Variations

Board Meeting Outcome

Q4 Financial Results

Voting Results Disclosure

Convertible Warrants Issued

Scrutinizer's Report Submitted

Extraordinary General Meeting

Corrigendum Issued

Corrigendum Publication

Books Maintenance Change

300+ Dealers Appointed

Confirmation Certificate Su...

Investor Presentation

Extraordinary General Meeting

Extraordinary General Meeting

Convertible Warrants Offering

New Director Appointed

Board Meeting Outcomes

Trading Window Closure

Financial Results Clarifica...

Financial Results Submitted

Dairy Expo Participation

Strong Q2 Results

No Fund Deviation

Financial Results

Financial Results

Export Order Received

Repeat Order Received

Confirmation Certificate

Investor Presentation

Trading Window Closure

New Auditors Appointed

Annual General Meeting

BIS Certification Awarded

BIS Certification Received

Financial Results Submission

AGM Announcement

Annual General Meeting

Book Closure Notice

Board Meeting Outcomes

Statement of Deviation or V...

Financial Results Submission

Financial Results Approval

Expansion Plans

Cattle Feed Expansion

Confirmation Certificate Su...

Prestigious Order Received

Trading Window Closure

Strategic Partnership

Partnership Announcement

Rights Issue Update

Ajooni Biotech Land Acquisi...

Moringa Plantation

Rights Issue Approval

Transcript Availability

Moringa Project Launch

Investor Presentation

Investor Call Recording Link

Financial Performance

Financial Results

Statement of Deviation in F...

Financial Results Approval

Financial Results Submission

Ajooni Biotech Board Meetin...

Partnership Announcement

Advertisement Submission

Expansion Plans

Expansion Announcement

Investor Presentation

Rights Issue Approved

Letter of Offer Approval

Biotech Expansion

Right Issue Update

Upgrade & Rights Issue

Credit Rating Upgrade

Rights Issue Record Date Re...

Revised Rights Issue

Record Date Revision

Disclosure Submission

Disclosure Submission

Export Order Received

Connection with Avon Animal...

Partnership Agreement

Contract Agreement

Confirmation Certificate Fi...

Trading Window Closure

Revised Record Date

Rights Issue Outcome

Record Date Revision

Rights Issue Committee Meet...

Record Date Announcement

Rights Issue Record Date

Rights Issue Committee Outcome

Publication of Financial Re...

Deviation Statement

Appointment of Auditors

Financial Results Submission

Quarterly Earnings - Financ...

Functional Website

Confirmation Certificate Su...

Trading Window Closure

Right Issue Committee Meeti...

Financial Results Submission

Deviation Announcement

Trading Window Closure

Revised Voting Results

Increase in Authorized Capital

Amendment to AOA/MOA

Publication of Financial Re...

Board Meeting Outcome

Board Meeting Outcome

External Links:

Data:

Ajooni Biotech Limited's Board meeting on January 03, 2025, approved increasing authorized share capital from Rs. 40 Crores to Rs. 50 Crores, and issuing up to 5 Crores convertible warrants at Rs. 9 each, while also appointing a new independent director and planning an Extraordinary General Meeting on February 03, 2025.

AI Assistant

Ajooni Biotech Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.